Coviu to integrate ResApp diagnostic app into telehealth platform

ASX-listed digital health company ResApp is working with telehealth software developer Coviu to integrate ResApp’s acute respiratory diagnostic app into Coviu’s platform to help clinicians diagnose respiratory disease in a telehealth setting.

ResAppDx-EU is a TGA-approved smartphone app that uses machine learning algorithms that analyse a patient’s cough sounds to diagnose disease.

Posted in Australian eHealth

Tags: Coviu, ResApp Health

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2022 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit